BDAL’s Q1 New Bookings Rise by 25 Percent

Bruker Daltonics said last week that its new order bookings for life-science systems grew by 25 percent during the first quarter of 2002, compared with the same quarter of 2001. “We see real excitement and increasing demand for our Ultraflex TOF/TOF system,” Frank Laukien, Bruker Daltonics’ CEO, said in a statement. “Our shipments and installations for the Ultraflex are ramping up smoothly.”


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.